Johnson & Johnson (J&J) on Tuesday said that it was partnering with Apple Inc to use an iPhone app and the Apple Watch to study how earlier detection of atrial fibrillation impacts stroke in people aged 65 or older.
Last year, Apple’s Heart Study — which analyzed the role of wearable devices in identifying potential heart problems — found that the watch could accurately detect atrial fibrillation, the most common type of irregular heartbeat.
Atrial fibrillation increases the risk of stroke more than fivefold, the American Heart Association said.
Apple chief operating officer Jeff Williams said that the initial study proved the Apple Watch could detect atrial fibrillation with a low rate of false alarms, which helped Apple gain clearance from the US Food and Drug Administration for a watch app that takes an electrocardiogram (EKG) measurement.
The study with J&J aims to show if early detection leads to better health outcomes.
“We want to follow the science all the way to the end, no matter what the outcomes are, and run this longitudinal study,” Williams said. “It’s not something that we have to do, but it’s the right thing to do.”
The joint effort, called “Heartline,” is significant because J&J is one of the world’s largest medical device makers and pharmaceutical companies.
“What we bring is clinical study capability on a very large scale,” J&J chief scientific officer Paul Stoffels said, adding that the study would track 150,000 participants with long-term follow-ups over two years.
The study could also reach a different population than Apple’s original heart study, which included 400,000 participants, but faced scrutiny from medical experts because more than half of the people who signed up were under 40, a group already at low risk for atrial fibrillation.
J&J said that it wants to target a population with a higher risk.
Paul Burton, vice president of medical affairs at the J&J subsidiary running the study, said that 70 percent of patients experiencing the condition are over 65.
“What we’re trying to do here is definitively answer that question: If you take wearable technology and couple it with an app, can you reduce the risk of a stroke or death?” Burton said.
The J&J study would be open to the more than 40 million people enrolled in traditional US Medicare plans, which cover people aged 65 and older, as well as the disabled. Study participants would be randomly assigned to either use only an iPhone app or use the app in conjunction with a watch capable of taking an EKG.
If patients who enroll are assigned to the arm of the study using the Apple Watch, they would be prompted to acquire one of the devices, which study officials said the participants could either purchase on their own for personal use for US$49 or borrow free of charge for the study.
The latest Apple Watch model starts at list price of US$399.
Burton said that J&J and Apple were sharing the cost of subsidizing the watches.
The study would pay participants, who must agree to share their Medicare claims data.
Apple and J&J officials said that was vital to proving whether the use of the app and watch lead to reduced stroke risk.
NOT ALL GOOD: Analysts warned that other data for last month might be less rosy due to the virus and analysts expect the PMI to contract again next month Chinese factory activity saw surprise growth last month as businesses went back to work following a lengthy shutdown, but analysts said that the economy faces a challenging recovery as external demand has been devastated by the COVID-19 pandemic, while the World Bank said that growth could screech to a halt. China is slowly returning to life after months of tough restrictions aimed at containing the virus, which put millions of people into virtual house arrest and brought economic activity to a near standstill. The strict measures saw a closely watched gauge of manufacturing plunge to its lowest level on record in February,
The output of the global smartphone industry this year is to contract by 7.8 percent on an annual basis as the COVID-19 pandemic ushers in a global recession, Taipei-based market researcher TrendForce Corp (集邦科技) said in a report on Monday. The global production of smartphones is expected to fall to 1.29 billion units, as the pandemic dampens demand for consumer electronics, leading to a decline in shipments across Europe and North America, TrendForce said. With consumers delaying smartphone purchases and thereby lengthening the device replacement cycle, overall prices would suffer a setback that is expected to negatively affect the profitability of smartphone
ELECTRONICS Lite-On delays sale of unit Lite-On Technology Corp (光寶科技) yesterday said it would postpone the sale of its solid-state drives (SSD) business to Kioxia Holdings Corp, formerly known as Toshiba Memory Holdings Corp, due to disruptions amid the COVID-19 pandemic. Last year, the Taiwan-based electronics components supplier struck the deal with the Japanese firm, agreeing to sell the unit for US$165 million. Citing unfinished integration work due to the pandemic, Lite-On has deferred today’s closing date until further notice, adding that the delay would not have a negative effect on the unit’s operations. AUTO PARTS Hiroca approves dividend Automotive interior parts supplier Hiroca
ALL ABOUT STRATEGY: The company is optimistic, saying that its gross margin should increase year-on-year, but it is scaling back on its plans to expand capacity Quang Viet Enterprise Co (QVE, 廣越), which makes down jackets and garments for sportswear and outdoor brands including Adidas AG, yesterday said that revenue might drop 5 to 10 percent annually this year as some customers trimmed orders in response to the COVID-19 pandemic. That would mark its first revenue decline since 2016. Quang Viet posted record-high revenue of NT$16.26 billion (US$537.45 million) last year, up 22 percent from 2018. Down jackets made up 40 percent of it revenue last year. North Face Inc and Patagonia Inc are this year likely to reduce orders by 20 to 30 percent from a